ABEO
Abeona Therapeutics Inc.NASDAQHealthcare$4.82+5.24%ClosedMarket Cap: $275.0M
As of 2026-04-06
Valuation
P/E (TTM)
3.86
PEG
0.02
P/B
1.58
P/S
46.66
EV/EBITDA
-2.54
DCF Value
$0.79
FCF Yield
-31.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
26.3%
Operating Margin
-1536.9%
Net Margin
1223.1%
ROE
53.2%
ROA
32.4%
ROIC
-44.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.4M | 31.7% | $-22.9M | $-20.5M | $-0.36 | — |
| FY 2025 | $5.8M | 73.7% | $-89.4M | $71.2M | $1.01 | — |
| Q3 2025 | $0.00 | -Infinity% | $-24.0M | $-5.2M | $-0.10 | — |
| Q2 2025 | $400.0K | 75.0% | $-22.8M | $108.8M | $1.71 | — |
| Q1 2025 | $0.00 | NaN% | $-19.7M | $-12.0M | $-0.24 | — |
| Q4 2024 | $0.00 | -Infinity% | $-16.7M | $-9.3M | $-0.23 | — |
| FY 2024 | $0.00 | -Infinity% | $-64.2M | $-63.7M | $-1.55 | — |
| Q3 2024 | $0.00 | NaN% | $-15.3M | $-30.3M | $-0.63 | — |
| Q2 2024 | $0.00 | NaN% | $-17.9M | $7.4M | $0.14 | — |
| Q1 2024 | $0.00 | NaN% | $-14.3M | $-31.6M | $-1.16 | — |
| Q4 2023 | $0.00 | -Infinity% | $-13.2M | $-16.6M | $-0.65 | — |
| FY 2023 | $3.5M | 54.1% | $-47.1M | $-54.2M | $-2.53 | — |